PURPOSE: We compared early results of homograft aortic root replacement (ARR) in native (NVE) and prosthetic (PVE) aortic valve endocarditis in order to identify predictors for early mortality (<30 days). METHODS: Between 05/1986 and 12/2007, 1,163 endocarditis patients were operated upon. Of these, 221 patients (n = 185 men, median age 55 years) underwent homograft ARR due to 99 cases of NVE (45%) and 122 of PVE (55%) aortic root endocarditis. Demographics, clinical differences, survival rates and predictors of early mortality were analyzed. Follow-up (mean 5.2 +/- 0.4 years, maximum 18.4 years) was completed in 96.8% with a total of 1,127 patient years. RESULTS: Main causes of the 47 (21.2%) early deaths were septic multiorgan failure in 23 (48.9%) and myocardial failure in 10 (21.3%) patients with a significantly better survival for NVE than for PVE patients (patients = 0.029). The highest ORs were found in the univariate analysis for preoperative development of septic shock (OR 14.28), preoperative necessity of ventilation (OR 7.08), high doses of catecholamines (OR 5.60), severe aortic root destruction (OR 5.12), emergency operation (OR 4.25) and persistent fever despite antibiotic treatment (OR 4.11). Multivariate analysis showed that preoperative ventilation (OR 5.43), persistent fever under antibiotic treatment (OR 2.84) and prosthetic endocarditis (OR 2.32) were independent risk factors for early mortality. CONCLUSIONS: Our results suggest that early outcome could be improved if patients were referred earlier for surgery. A multidisciplinary approach is necessary, involving at least specialists in intensive care medicine, cardiology, infectious disease and cardiac surgery in order to identify the optimal time for surgery and decrease early mortality.
PURPOSE: We compared early results of homograft aortic root replacement (ARR) in native (NVE) and prosthetic (PVE) aortic valve endocarditis in order to identify predictors for early mortality (<30 days). METHODS: Between 05/1986 and 12/2007, 1,163 endocarditispatients were operated upon. Of these, 221 patients (n = 185 men, median age 55 years) underwent homograft ARR due to 99 cases of NVE (45%) and 122 of PVE (55%) aortic root endocarditis. Demographics, clinical differences, survival rates and predictors of early mortality were analyzed. Follow-up (mean 5.2 +/- 0.4 years, maximum 18.4 years) was completed in 96.8% with a total of 1,127 patient years. RESULTS: Main causes of the 47 (21.2%) early deaths were septic multiorgan failure in 23 (48.9%) and myocardial failure in 10 (21.3%) patients with a significantly better survival for NVE than for PVE patients (patients = 0.029). The highest ORs were found in the univariate analysis for preoperative development of septic shock (OR 14.28), preoperative necessity of ventilation (OR 7.08), high doses of catecholamines (OR 5.60), severe aortic root destruction (OR 5.12), emergency operation (OR 4.25) and persistent fever despite antibiotic treatment (OR 4.11). Multivariate analysis showed that preoperative ventilation (OR 5.43), persistent fever under antibiotic treatment (OR 2.84) and prosthetic endocarditis (OR 2.32) were independent risk factors for early mortality. CONCLUSIONS: Our results suggest that early outcome could be improved if patients were referred earlier for surgery. A multidisciplinary approach is necessary, involving at least specialists in intensive care medicine, cardiology, infectious disease and cardiac surgery in order to identify the optimal time for surgery and decrease early mortality.
Authors: Olcay Aksoy; Daniel J Sexton; Andrew Wang; Paul A Pappas; Wissam Kourany; Vivian Chu; Vance G Fowler; Christopher W Woods; John J Engemann; G Ralph Corey; Tina Harding; Christopher H Cabell Journal: Clin Infect Dis Date: 2007-01-02 Impact factor: 9.079
Authors: Evelyn E Hill; Marie-Christine Herregods; Steven Vanderschueren; Piet Claus; Willy E Peetermans; Paul Herijgers Journal: Ann Thorac Surg Date: 2008-05 Impact factor: 4.330
Authors: O Lund; V Chandrasekaran; R Grocott-Mason; H Elwidaa; R Mazhar; A Khaghani; A Mitchell; C Ilsley; M H Yacoub Journal: J Thorac Cardiovasc Surg Date: 1999-01 Impact factor: 5.209
Authors: Christopher H Cabell; Elias Abrutyn; Vance G Fowler; Bruno Hoen; Jose M Miro; G Ralph Corey; Lars Olaison; Paul Pappas; Kevin J Anstrom; Judith A Stafford; Susannah Eykyn; Gilbert Habib; Carlos A Mestres; Andrew Wang Journal: Am Heart J Date: 2005-11 Impact factor: 4.749
Authors: M R Moon; D C Miller; K A Moore; P E Oyer; R S Mitchell; R C Robbins; E B Stinson; N E Shumway; B A Reitz Journal: Ann Thorac Surg Date: 2001-04 Impact factor: 4.330
Authors: Tirone E David; Gheorghe Gavra; Christopher M Feindel; Tommaso Regesta; Susan Armstrong; Manjula D Maganti Journal: J Thorac Cardiovasc Surg Date: 2006-11-30 Impact factor: 5.209
Authors: P Tornos; B Iung; G Permanyer-Miralda; G Baron; F Delahaye; Ch Gohlke-Bärwolf; E G Butchart; P Ravaud; A Vahanian Journal: Heart Date: 2005-05 Impact factor: 5.994
Authors: Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch Journal: JAMA Date: 2002-07-03 Impact factor: 56.272
Authors: Michele Musci; H Siniawski; C Knosalla; O Grauhan; Y Weng; M Pasic; R Meyer; R Hetzer Journal: Clin Res Cardiol Date: 2006-04-10 Impact factor: 6.138
Authors: Mahmoud Diab; Albrecht Guenther; Christoph Sponholz; Thomas Lehmann; Gloria Faerber; Anna Matz; Marcus Franz; Otto W Witte; Mathias W Pletz; Torsten Doenst Journal: Clin Res Cardiol Date: 2016-04-27 Impact factor: 5.460
Authors: Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries Journal: Crit Care Date: 2011-09-13 Impact factor: 9.097